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HISTAMINE RELEASE IN MAN BY PROPANIDID AND THIOPENTONE:
PHARMACOLOGICAL EFFECTS AND CLINICAL CONSEQUENCES
W. LORENZ, A. DOENICKE, R. MEYER, H. J. REIMANN, J. KDSCHE, H. BARTH,
H. GEESING, M. HUTZEL AND B. WEISSENBACHER*
SUMMARY
Using a new, highly sensitive and specific method for the determination of histamine
in human plasma, it was shown that release of histamine followed injection of propanidid
and thiopentone. Observations of gastric secretion, arterial pressure and pulse rate
supported these findings. In normal persons the release of histamine had no special
clinical significance. On the other hand, when anaphylactoid reactions occurred following
propanidid injection histamine release was so massive as to explain the severe clinical
signs and symptoms observed. In this study no reactions occurred following thiopentone
injection. Although it seems likely that massive histamine release can occur during
anaphylactoid reactions with this anaesthetic, we have no observations to confirm this.
In one case it was shown that premedication with glucocorticoids and anti-histaminics
and therapy with plasma substitutes could prevent the development of a severe reaction.
It has been shown that drugs used before and dur-
ing the administration of anaesthetics, in man and
animals, may cause the release of histamine (for
reviews see Paton, 1959; Murphy, 1962; Rothschild,
1966; Lorenz and Werle, 1971). Sometimes direct
methods have been used when histamine itself was
measured in body fluids or in tissues. More often,
however, indirect methods have been employed,
such as the measurement of gastric secretion,
observation of the decrease in peripheral arterial
pressure, tachycardia and increase in bronchial
resistance. These reactions are, however, specific for
histamine only in a limited sense.
We have developed an assay by which histamine
can be measured specifically in human plasma
(Lorenz et al., 1971c) and have studied the release
of histamine in man caused by two commonly used
anaesthetic drugs, namely propanidid and thiopen-
tone. Recent reports of anaphylactoid reactions dur-
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ing anaesthesia with both substances led us to
undertake this investigation. To demonstrate, how-
ever, that the increased concentration of plasma
histamine was actually free, pharmacologically
active histamine, we studied gastric acid secretion,
heart or pulse rate, and peripheral arterial pressure
in the subjects of the investigation.
MATERIALS AND METHODS
Materials.
Drugs. Propanidid; Micellophor (Bayer, Lever-
kusen); thiopentone (Pentothal, Abbott, Ingelheim);
atropine sulphate (from University pharmacy);
clemastinet (Tavegil, HS 592, Sandoz, Niirn-
berg); prednisolone (Prednisolon "Lentia", Lentia
Munich); suxamethonium (Lystenon, Lentia,
Munich); halothane (Fluothane, Rheinpharma,
Heidelberg); antazoline (Antistin, Ciba, Basel);
dextran (Longasteril-75, Fresenius, Bad Homburg).
Reagents. Histamine dihydrochloride puriss.
(Fluka, Buchs); o-phthaldialdehyde puriss. p.a.
(Fluka, Buchs) (recrystallized from petrol ether
p.a., b.p. 40-60°); Methanol, n-heptane, inorganic
acids and bases as Uvasol (Merck, Darmstadt);
n-butanol (for chromatography, Riedel de Haen,
Seelze near Hannover); Dowex 50 W-X8, H+,
mesh 200-400 (Serva, Heidelberg); unless other-
wise stated, only twice distilled water was used.
J Known also as neclastinum.
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Heparin for biochemical research (180 i.u./mg)
(Hoffmann-La Roche, Grenzach); 0.1N NaOH for
titration of gastric juice (Titrisol, Merck, Darm-
stadt).
Subjects.
The investigations were carried out on 143
healthy volunteers and 1 patient. Consent was
obtained. The volunteers, who had healthy medical
histories consisted of 140 male and 2 female students
and anaesthesists between the ages of 22 and 31
years, weighing between 54 and 100 kg. One
subject (A.D.) was one of the investigators. The
patient had a compound comminuted fracture of
the left lower leg and a compound fracture of the
right femur as a result of an industrial accident. He
was an alcoholic, but was otherwise clinically
healthy, having no special previous medical history.
Before each study the test persons and the patient
had fasted for at least 12 hours.
Sequence and arrangement of investigation.
Studies were conducted from 7 a.m. to 9 a.m. in
a quiet well-lit room. The procedure was as
follows (fig. 1). A nasogastric tube was introduced
into the stomach under radiological control. After
the tube was fixed to his nose, the subject lay
down with the upper body slightly raised. Leads
Blood Pressure
Injection of
Test Substance
ECG
Gastric Acid
Venous Blood:
Whole Blood Hislamine
( Jm/ Plasma Histamine
x ' v Basophils
Eosinophils
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Basophils
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FIG. 1. Scheme of the arrangement of investigation in
the test subjects. For explanations see text under Methods.
for the electrocardiogram were attached to the
extremities and a sphygmomanometer (Riva-Rocci)
was applied to the right upper arm. A polyethylene
cannula (Braunule, Braun, Melsungen) was inserted
into a superficial vein in each arm, the right being
used for the injection of the anaesthetic or solvent
and of other drugs, and the left for withdrawal of
blood for histamine assay in plasma and whole
blood, and for leucocyte counts and blood smears.
When in any one of the investigations, a solvent
and agent, or an agent alone and together with
atropine, was employed on one and the same subject,
then the sequence of administration of the solutions
was alternated. Thus, if Micellophor was used first
and then propanidid, in the next subject propanidid
was used first and then the solvent. Two to four
weeks elapsed between the first and second investiga-
tion.
Histamine infusion.
The same order was adhered to in studies with
histamine infusion. Gastric acid secretion was not
determined because the dose-effect relationship
between histamine infusion and gastric acid secre-
tion in humans is well known from the literature
(Lawrie, Smith and Forrest, 1964).
The histamine solution was prepared from a
sterilized stock solution from the university
pharmacy, diluted with physiological saline, and
drawn up in a 50-ml polyethylene syringe.
The intravenous infusion was carried out in the
right arm using the infusion apparatus Unita II
(Braun, Melsungen), while, as in the other investiga-
tions, blood was withdrawn from the left median
cubital vein. NaCl solution 0.9 per cent was first
infused, followed by histamine from a separate
syringe, and then physiological saline.
In order to avoid any side effects of histamine
infusion (headache, flush, etc.), antazoline (2 mg/kg)
was injected intravenously just before the highest
dose of histamine was administered.
Determination of the Various Parameters.
Histamine assay in whole blood and plasma.
From the left arm, 5.0 ml of blood was drawn
into a polyethylene syringe 15 min before and
immediately before injection of anaesthetic or
solvent, and at 1, 5, 10, 20 and 30 min after
injection. The samples were put immediately into
centrifuge tubes containing 5.0 ml of IN HCIO4
and centrifuged for 5 min at 1800 g; 4.0 ml of the
supernatant was stored for several days at — 20°C
and used later for histamine assay.
Immediately after withdrawal of samples for
whole blood histamine determination, 19.5 ml of
blood was withdrawn slowly and with care to avoid
bubble formation, using a polyethylene syringe con-
taining 2 mg heparin dissolved in 0.5 ml of 0.9 per
cent NaCl solution. After gently mixing the con-
tents in the syringe, it was transferred slowly and
with minimum pressure into a 30-ml polyethylene
centrifuge tube pre-cooled thoroughly in an ic et 
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cold water bath, and centrifuged immediately for
30 min at 1000 g and 1-2 °C. 6.0 ml of plasma was
withdrawn, immediately mixed with 3 ml of 2N
HCIO, and centrifuged for 10 min at 1800 g. The
whole supernatant was filtered through a paper filter
and used for histamine assay immediately or was
stored in the freezer at — 20 °C, and histamine
determined several days later.
The amine in whole blood was measured
fluorometrically according to the method of Lorenz
and associates (1970) after isolation by ion-
exchange chromatography on Dowex 50 W-X8.
Histamine in human plasma was determined
according to the method of Lorenz and associates
(1971c) after isolation by chromatography on
Dowex 50 and subsequent extraction into alkaline
n-butanol. The histamine content in whole blood
and plasma is given in ng histamine base/ml of
body fluid.
Determination of gastric acid secretion (Lorenz
et al., 1969; Lorenz, 1971).
While the subject was sitting, a nasogastric tube
with X-ray contrast strips (Levin No. 12-14) was
inserted under radiological control. After complete
emptying of the stomach by manual suction using
a syringe the tube position was further tested by
instillation of 20 ml of 0.9 per cent NaCl solution
(37° C) and re-aspiration of the same. Basal secre-
tion was then collected by suction at intervals of
2 min over a period of 30 min. When atropine had
to be used, a dose of 0.01 mg/kg was administered
intravenously 15 min after the beginning of the
collection. At the end of the 30 min, the anaesthetic
was injected and the gastric juice withdrawn by
suction every minute and collected in portions cor-
responding to the blood withdrawals, i.e., in two
3-min portions, one 4-min portion and two 10-min
portions. The volume of gastric juice was measured
and the acid output determined for each portion
by titration with 0.1 NaOH up to pH 7.0 using a
glass electrode. The acid output was given in m.equiv
HCl/min (Lorenz et al., 1969).
Determination of heart rate and arterial pressure.
The heart rate was determined by measuring the
average internal length in lead II of the standard
e.c.g. and given as beats/min (Heinecker, 1970).
The arterial pressure (mm Hg) was determined by
indirect sphygmomanometric measurement (Riva-
Rocci) according to the method of Burton (1965).
Because the subjects were all young people (very
little or no arteriosclerosis), the arterial pressure
values obtained by the indirect method probably
differed little from those obtained by a direct
method. Indeed, the values measured by indirect
methods during anaesthesia agreed well with those
which were measured by direct methods (Henschel
and Buhr, 1965; Avrucki and Zinovjev, 1969;
Soga and Beer, 1971, personal communication).
Determination of basophil granulocyte content
in peripheral venous and capillary blood.
At the same time as the blood was withdrawn
for histamine assays in whole blood and plasma,
two blood smears and one leucocyte count were
made using venous blood. The leucocyte count was
performed according to Miiller, Seifert and v.
Kress (1962), while the blood differential was deter-
mined according to Pappenheim, whereby 1000
cells from each sample were counted. The content
of basophils in venous and capillary blood was
determined according to Hamerston and associates
(1956) (number of leucocytes/mm3 and per cent of
basophils in the blood smear). The results of
Moore and James (1953) and Hamerston and
associates (1956) showed that the values from such
an indirect method agree well with those obtained
by direct methods. The content of basophils in the
blood is given in number of cells/mm3.
Cutaneous prick test for testing of allergens.
In order to test an antigen-antibody reaction as
the cause of histamine release by propanidid, a
prick test (for method, see Stiittgen and Ippen,
1969) was performed in co-operation with H. Band-
mann* in all subjects who showed clinical
symptoms of an anaphylactoid reaction to pro-
panidid. The anaesthetic dissolved in Micellophor,
and the solvent alone were applied separately on
the upper arm. As controls, a 0.9 per cent NaCl
solution and histamine dissolved in physiological
saline (1:10,000) were employed. The reaction tests
were made not sooner than 4 weeks after the
clinical reaction.
RESULTS
Histamine Release by Propanidid and Thiopentone.
Concentrations of plasma histamine after
propanidid, Micellophor and thiopentone.
After propanidid in doses which are commonly
used for anaesthesia in man, the mean histamine
•Dermatology Clinic, University of Munich.
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level in plasma increased significantly to about 350
per cent of the norm (fig. 2). The highest value was
found at 5 min after injection. The concentration
remained elevated for some time after the end of
anaesthesia. Up to 30 min was needed before initial
levels were approached. The i.v. administration of
atropine had no significant influence on plasma
histamine concentration, although this agent has
been shown to be a histamine liberator in humans,
dogs and cats (Rothschild, 1966).
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FIG. 2. Increase of plasma histamine concentration in
man after intravenous injection of propanidid. Mean values
with SEM. Twelve subjects were anaesthetized with
propanidid 7 mg/kg, injection time 20 sec.
It has been said that the solvent of propanidid,
Cremophor, or currently Micellophor, is a possible
cause of histamine release in humans. As wetting
agents, both liberate histamine in dogs and cats
(Lorenz et al., 1971b), but have no effect on humans
(Lorenz et al., 1969). In this study the same subjects
who were treated with propanidid were also investi-
gated using Cremophor and Micellophor alone.
The increase of plasma histamine concentration of
about 20 per cent, which was found in subjects, is
not statistically significant.
In one subject (A.D.), however, there was a
slight reaction to the injection of Micellophor.
One min after the administration of the solvent in a dose
of 0.15 ml/kg in 20 sec there was slight reddening of the
face. 2 min later, the redness became brighter, the face
felt hot and he experienced itching behind the ears. 5 min
after injection, the eyelids began to swell. 10 min later,
he had pain in the stomach, and heartburn, and his nose
and ears became bright red. 16 min after injection,
prednisolone 50 mg was administered intravenously. 4 min
thereafter, improvement of the complaints was observed,
but during the next 15 min the face and eyes remained
swollen and the subject exhibited marked lassitude. On
the other hand, neither tachycardia nor change in blood
pressure was observed and dyspnoea or headache did not
occur.
The plasma histamine concentration in this subject
before injection of Micellophor was 1.4 ng/ml. At 1, 3,
5, 10, 16, 20 and 30 min after injection, the plasma
histamine level was 2.3, 1.8,1.1, 2.5, 2.3, 2.2 and 1.7 ng/mL
The slight increase in plasma histamine concentration could
hardly be responsible for the symptoms experienced (cf.
the results with histamine infusion which are reported
below). Another cause of these symptoms must therefore
be assumed.
The Micellophor injection was repeated four weeks after
this incident and resulted neither in clinical symptoms nor
any increase of plasma histamine concentration. The prick-
test with Micellophor was negative.
Further, after injection of Micellophor in all
subjects, also in the one patient who reacted to
propanidid with an incident, neither clinical
symptoms nor increases of plasma histamine con-
centration were found. Thus, it can be concluded
that propanidid (anaesthetic drug plus solvent), and
not Cremophor or Micellophor alone, releases
histamine in humans.
Thiopentone, in doses which are used in anaes-
thesia, also led to an elevation of plasma histamine
concentration (fig. 3), the degree of elevation being
similar to that following propanidid. The plasma
concentration fell at approximately the same rate
as after propanidid. The solvent used for thiopen-
tone was 0.9 per cent NaCl solution. Rapid injec-
tion of this solvent did not lead to any increase in
plasma histamine levels.
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FIG. 3. Increase of plasma histamine concentration in
man after intravenous injection of thiopentone. Mean
values with SEM. Eight subjects were anaesthetized with
thiopentone 5 mg/kg, injection time 20 sec. Atropine 0.01
mg/kg i.v. was given as premedication 10 min before
thiopentone.
Plasma histamine levels during infusion of
histamine and correlation with heart rate
and blood pressure.
In three healthy students who were also included
in the investigations with anaesthetics, the follow-
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ing two questions were studied: (1) Does the dose
of histamine needed to produce a moderate to
medium stimulation of gastric acid secretion also
increase the plasma histamine level? (2) Does a
relationship exist between the dose of histamine
infused and the elevation of plasma histamine
level?
With the new histamine assay developed in our
laboratory, it was now possible to show (1) that an
increase of plasma histamine concentration can be
measured after infusion of relatively low doses of
histamine (18-90 ng/kg/min), and (2) that a rela-
tionship exists between the doses of histamine
infused and the elevation of plasma histamine level
(fig. 4). Therefore, by determination of plasma
histamine concentration after administration of an
anaesthetic, the amount of histamine that has been
released during this treatment can be estimated.
Blood ,20
Pressure ,oo
[ mm Hg 1 go
60J
Heart
Rate
Plasma 60
Histamine
Concen-"°
tration
I ng/ml I
Histamine
Infusion
* — * — i — • — * — « '
..UN i
Time i ••
FIG. 4. Plasma histamine concentration, blood pressure
and heart rate after intravenous infusion of increasing
doses of histamine. Mean values with SEM. Three subjects
were tested.
Histamine up to a dose of 45 ng/kg/min, which
produces a half-maximum gastric secretion (Lawrie,
Smith and Forrest, 1964), did not produce com-
plaints or clinical symptoms in any of three sub-
jects. No effect on blood pressure or heart rate was
observed (relatively sensitive indicators of histamine
release). Only with a dose of 90 ng/kg/min, and
despite anti-histamine medication, was there any
clinical reaction and that was confined to slight
tachycardia in one volunteer only, accompanied by
mild headache.
Gastric acid secretion after propanidid,
Micellophor and thiopentone.
To study the problem whether the increase of
histamine in plasma during anaesthesia actually is an
increase of free, pharmacologically active histamine,
we investigated one of the most sensitive reactions
of the human organism to histamine, that is an
increased gastric acid secretion.
Rapid injection of propanidid in five volunteers
resulted in an approximately half-maximum gastric
acid secretion. The increase of acid output ran
parallel to the increase in plasma histamine con-
centration (fig. 5). After 30 min, the plateau of
basal secretion was again reached. When Micel-
lophor was injected, only a small and non-significant
increase of gastric secretion was found.
After injection of thiopentone, stimulation of
gastric acid secretion could also be demonstrated
(fig. 6). The acid output and the secretion curve
are in complete accord with those observed after
propanidid injection. For safety purposes, thiopen-
tone was not administered without atropine pre-
medication. After intravenous injection of 10 ml
physiological saline, the solvent of thiopentone, no
stimulation of gastric acid secretion was observed.
Heart rate and blood pressure after
propanidid, Micellophor and thiopentone.
During the first 5  min after propanidid injection,
there was an increase in the heart rate (table I). This
response has often been described in the literature
(see Discussion). The systolic and diastolic pressures
decreased significantly only during the first 2  min,
that is before the maximum increase in plasma
histamine concentration had been reached (fig. 5).
Therefore, it is very improbable that the initial
tachycardia and acute peripheral hypotension have
a connection with the release of histamine into the
plasma. The stimulation of gastric acid secretion
and the decrease of basophils in the blood, on the
other hand, ran almost parallel with the increase of
plasma histamine concentration (fig. 5). In fact, the
maximum mean plasma histamine level of 3.1
ng/ml was such that, from the results of histamine
infusion studies (fig. 4), tachycardia or hypotension
would not have been expected.
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FIG. 5. Histamine concentration in whole blood and
plasma, basophils, gastric acid secretion, blood pressure
and heart rate after intravenous injection of propanidid.
Mean values with SEM. Five subjects were tested after
injection of propanidid 7 mg/kg, injection time 20 sec.
In each subject all parameters were studied simultaneously.
Values at zero time for heart rate ( # • ) and blood
pressure ( # # ) are calculated according to table I.
Blood pressure is given as systolic-diastolic pressure.
10 15 20
Time [ mm 1
FIG. 6. Histamine concentration in whole blood and
plasma, basophils, gastric acid secretion, blood pressure
and heart rate after intravenous injection of thiopentone.
Mean values with SEM. Five subjects were tested after
the injection of thiopentone 5 mg/kg, injection time 20 sec.
In each person all parameters were studied simultaneously.
Values at zero time for heart rate ( # # ) and blood
pressure ( # # ) are calculated according to table I.
TABLE I. Heart rate and blood pressure in man after intravenous injection of propanidid,
Micellophor and thiopentone.
Time after
(min)
0
1
2
3
5
10
15
20
Heart rate
(beats/min)
71=12
63±6
116±10
(P< 0.001)
90±14
(P<0.001)
78 ±9
(P < 0.001)
69±6
(P< 0.025)
65 ±6
(—)
64±6
64±6
(—)
Propanidid
Blood pressure
(mm Hg)
Systolic
124±9
107±ll
(P< 0.001)
113±10
(P<0.01)
117±8
(P<0.1)
124±11
(—)
I28±ll
(P<0.4)
128±11
127±11
(—)
Diastolic
74±8
66±8
(P< 0.025)
72±9
(—)
73 ±9
(—)
81±8
(P<0.05)
83±11
(P<0.05)
84±10
(P<0.02)
79±8
(P < 0.2)
Heart rate
t beats/min^
n=12
72±I5
73 ±14
72 ±12
73 ±14
73 ±14
71±13
70±12
69 ±10
Micellophor
Blood pressure
(mm Hg)
Systolic
120±7
122±9
123 ±9
121±10
122±9
121 ±9
119±8
120±9
Diastolic
79 ±9
80±8
80±10
81±11
80±9
81 ±9
79±8
79±9
Heart rate
n-12
67 ±10
83±U
(P < 0.005)
82±8
(P< 0.001)
72±11
(P<0.3)
70±9
(—)
69±11
(—)
67±11
66±11
(—)
Thiopentone
Blood pressure
(mmHg)
Systolic
120±7
113±9
(P<0.5)
118±7
118±7
115±8
117±8
119±6
118±10
Diastolic
78±12
74±9
75 ±8
73 ±10
73±7
(P<0.3)
76±6
77±6
77±8
Mean values with SD. Propanidid 7 mg/kg, injection time 20 sec, without atropine premedication. Micellophor 0.15 ml/kg, injection time 20 sec,
Thiopentone 5 mg/kg, injection time 20 sec, with premedication of atropine 0.01 mg/kg i.v. n=number of subjects tested. Statistical calculations according
to the Student /-test, P-values in parentheses. For further conditions see Methods. The values at zero time were obtained by calculating the average
values from 5 determinations during the last 5 min before the injection of the drugs ,  2011ow
nloaded from
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After injection of Micellophor, there was neither
a change of heart rate nor of arterial pressure
(table I).
Following thiopentone injection, there was a
slight and short-lived increase in heart rate and a
slight but insignificant fall in arterial pressure
(table I). As in the case of propanidid, the changes
in circulation occurred earlier than the maximum
increase of plasma histamine concentration. How-
ever, the stimulation of gastric secretion and the
decrease of basophils in the blood ran parallel to
the increase of plasma histamine (fig. 6). There-
fore, as with propanidid, there was no correlation
between the changes of heart rate and blood pres-
sure and the release of histamine into the plasma.
Because of a mean peak plasma histamine level of
3.2 ng/ml, this should also not have been expected.
From these results, as far as concerns histamine
release by propanidid and thiopentone, the follow-
ing conclusions may be drawn:
(1) In normal persons, the intravenous injection
of both anaesthetics resulted in the release of
histamine into the plasma, sufficient to
stimulate gastric acid secretion, but insufficient
to produce changes in the circulatory system.
(2) In persons with abnormalities relating to the
histamine storage or catabolism as well as in
those with an "allergic diathesis", the pos-
sibility cannot be excluded that release of
large amounts of histamine can be elicited
by propanidid or thiopentone sufficient to
evoke severe circulatory reactions. Such
incidents with propanidid are described later.
Release of large amounts of histamine during
incidents with propanidid.
In four subjects (three males and the patient)
allergic reactions or so-called anaesthetic incidents
were observed after injection of propanidid (table II).
The extent of the reaction to propanidid differed
greatly from person to person and ranged from a
clinical picture as severe as cardiac arrest, observed
as a baseline in the e.c.g. on the oscilloscope, to
relatively slight symptoms such as persistent tachy-
cardia and erythema.
In all four persons, the plasma histamine levels
before and after the injection of the anaesthetic
were measured. The increase in plasma histamine
concentration was in accordance with the degree of
severity of the clinical symptoms (table II). An
TABLE II. Anaphylactoid and allergic reactions after intravenous injection of propanidid.
Case
No.
Premedication
Exposure to propanidid
No. of
injection, Days
injection after first
speed injection
Plasma histamine
concentration (ng/ml)
Clinical observations
Before injection
injection (M)*
Atropine
0.01 mg/kg
Clemastine
0.04 mg/kg
Atropine
0.01 mg/kg
Atropine
0.01 mg/kg
Atropine
0.01 mg/kg
3rd; 70 sec 36
2nd; 20 sec 29
2nd; 20 sec 17
1st; 5 sec
Cardiac arrest 7$ min after injection, 8.0 100
severe hypotension (BP not
measurable, pulse not palpable),
tachycardia for about 90 min (160
beats/min), erythema of the face,
neck and thorax, bronchospasm,
cyanosis
Severe hypotension (BP not 0.8 26
measurable, pulse not palpable),
tachycardia for about 30 min (140
beats/min), bronchospasm, cyanosis,
oedema of the galea and eyelids,
erythema of the face, neck and
thorax
Slight hypotension (30 mm Hg, 0.85 12
tachycardia for 17 min (120
beats/min), bronchospasm, cyanosis,
erythema of the face and neck,
strong oedema of the face and galea
No significant hypotension, tachy- 0.9 6.4
cardia for 10 min (84 beats/min),
erythema of the face and neck, no
bronchospasm
* M=point of time at the maximum decrease of blood pressure, at cardiac arrest or maximum
tachycardia. For details see Methods.
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increase of the plasma histamine level of more than
90 ng/ml, as in the case of one patient studied,
caused a massive degree of hypotension. This is in
agreement with results obtained from studies of
histamine release in various animals, for instance
in pig and dog (Lorenz et al., 1968; Messmer et al.,
1970; Lorenz et al., 1971a, b).
CASE REPORTS
Case No. 1.
Numerous investigations were made on this patient with
his consent. This patient is the first case in the world
literature to show abnormally high plasma histamine
concentrations (Lorenz et al., 1971c; see below). The course
of investigations is here only briefly stated, but more details
can be found elsewhere (Doenicke et al., 1972).
The patient received the first propanidid anaesthetic
on August 4, 1969. An osteosynthesis was necessary for an
open supracondylar compound fracture of the right femur
and an open compound fracture of the left lower leg.
In this instance anaesthesia was uncomplicated.
On August 27, a second anaesthetic was administered
for an autoplastic graft. After a slow (40-50 sec) injection
of propanidid 7 mg/kg, the patient suffered an anaesthetic
incident with hypotension (60 mm Hg), tachycardia (110
beats/min) and moderate bronchospasm.
At this time we were convinced from the results
obtained in case No. 2 (see below) and those obtained
with Micellophor in dogs (Lorenz et al., 1971b), that
antihistamine premedication would prevent this response
to propanidid. With the patient's consent, which was
given after extensiye explanation of all side effects and
reactions which might occur after propanidid injection,
propanidid was likewise administered for further surgery.
On September 9, in addition to atropine 0.01 mg/kg i.v.,
the antihistamine clemastine 0.04 mg/kg i.v. was given as
premedication. Parallel to the measurement of blood
pressure and pulse rate, blood samples were withdrawn
for plasma histamine determinations.
After slow administration of propanidid 7 mg/kg, over
1 min, bronchospasm occurred 2 min after injection;
increasing tachycardia (120 beats/min) and a massive flush
were noted 3 min after injection. After 7 min, the
peripheral arterial pulse became impalpable and the blood
pressure was not measurable. 1\ min after injection,
cardiac arrest occurred. Immediately external cardiac
massage and further resuscitation were applied (i.v.
injection of 1 mg/kg of prednisolone, infusions etc.).
2 minutes later the peripheral pulse was again palpable
(160 beats/min), but the blood pressure was still not
measurable. 20 min after injection the pulse rate was
140 beats/min and the blood pressure 80/40 mm Hg.
45 min after injection, the pulse rate was 140 beats/min
and the blood pressure had risen to 140/80 mm Hg.
Before atropine and clemastine were injected the plasma
histamine concentration was 8.0 ng/ml.* 10 min after the
injection of both and immediately before the injection of
propanidid, the plasma histamine concentration was
9.2 ng/ml. It increased 2 min after propanidid
administration to 26.0 ng/ml, and 7 min after the injection
(immediately before cardiac arrest) to the very high value
of 100 ng/ml. During the time following, no blood samples
were withdrawn. However, this overwhelming increase
of histamine concentration in plasma explains the severe
* This value was more than 10 times higher than the
normal plasma histamine concentration which was found
to be 0.6 ng/ml (Lorenz et al., 1970, 1971c).
clinical symptoms. The administration of the antihistamine
clemastine was unable to prevent the reactions to such a
massive release of histamine.
The ineffectiveness of a strong antihistaminic drug in a
severe anaphylactoid reaction to propanidid raised the
highly important question of a suitable premedication and
therapy in such harmful events. Glucocorticoids have been
shown to prevent largely the pharmacological effects of
massive histamine release (Rocha e Silva, 1966). Predniso-
lone had been found very effective during the previous
incident in this patient. We discussed this problem with
him. The patient consented to another propanidid narcosis
which should be performed after premedication with high
doses of prednisolone and using a reduced dose of pro-
panidid (for details of this ethical problem see Doenicke
et al., 1972).
About 2 months later, on November 5, a further
operation (spongiosa-graft) was necessary. As pre-
medication, prednisolone 2 mg/kg, together with atropine
and clemastine, was intravenously administered. 15 min
later propanidid 5 mg/kg was injected over 40 sec. 4 min
thereafter, the pulse rate began to rise (120 beats/min).
The blood pressure increased insignificantly by about
20 mm Hg. Otherwise, the anaesthetic proceeded
completely without complications, the circulation para-
meters returning after 10 min to the values obtained before
anaesthesia.
Simultaneous determinations of histamine concentration
in plasma showed an unexpected decrease of plasma
histamine from 9.3 ng/ml immediately before to 2.8 ng/ml
5 min after the application of premedication. 4 min after
the injection of propanidid, the plasma histamine
concentration was still 2.8 ng/ml. After 8, 15 and 20 min
plasma histamine levels of 17.7, 12.5, and 4.7 ng/ml
respectively were measured. The increase from 2.8 to 17.7
ng histamine/ml should have led to clinical symptoms
when comparing it with the circulatory reactions during
histamine infusion and Case 3 in table II. Apparently, the
prednisolone therapy prevented any reaction.
On January 22, 1970, under propanidid anaesthesia, the
steel plate from osteosynthesis on the lower leg was
removed. After the same premedication as on November
5, 1969, propanidid 7 mg/kg was administered in 35 sec.
Within a half-hour, neither clinical symptoms of an
anaphylactoid reaction nor an increase of histamine
concentration in plasma was found.
The patient received the next and last propanidid
anaesthetic on November 2, 1970, a little more than
9 months later. The removal of a scale from the osteo-
synthesis was necessary. After the same premedication as
in the previous two operations, propanidid 7 mg/kg was
administered in 40 sec. The patient suffered a slight
hypotension lasting about 20 min (before propanidid,
120/80 mm Hg; after, 100/70 mm Hg), a tachycardia
lasting about 35 min, the maximum being at 15 min after
propanidid injection (before, 82 beats/min; 15 min after,
140 beats/min). After a pause of 40 min at normal pulse
rate, a tachycardia again set in with a maximum of 150
beats/min. This disappeared in the course of an hour.
The blood pressure remained constant during this time
with a value of 110/80 mm Hg, after plasma substitutes
(Longasteril, Laevulose) to a total volume of 1000 ml were
infused. Moreover, at the time of maximum tachycardia,
a relatively coarse tremor appeared which ceased after
about 20 minutes (cf. Lorenz et al., 1971a). During and
after the anaesthesia, no bronchospasm was observed.
The plasma histamine concentration before the pre-
medication was 9.3 ng/ml. It increased to 16.5 ng/ml
1 min after propanidid injection, to 30 ng/ml 5 min after
injection and to 45 ng/ml at 10 and 15 min after
propanidid injection. Thereafter, no blood was 
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because the operation began. At the time of maximum
tachycardia, the histamine level in plasma was also at its
highest. The premedication, however, was apparently able
to prevent almost completely the effects of such a
considerable histamine release. One may compare the
results of this last anaesthesia with those in figure 4
(histamine infusion) and in table II, as well as with the
results of the third anaesthetic administration to the patient,
to see that a severe hypotension and a severe clinical
picture would have been expected to develop.
Further investigations were made on this patient as
follows (described in detail by Doenicke et al., 1972).
Histamine concentration in whole blood (59 and 63.5
ng/ml on two different days) and basophil content of the
blood (52 cells/mm3) were in the normal range. An
anaesthesia with thiopentone (5 mg/kg i.v.) led only to an
insignificant increase of plasma histamine concentration
(about 1.4 ng/ml) and to no clinical symptoms relating
to an anaphylactoid reaction. The injection of Micellophor,
the solvent of propanidid, 3 months after the last
propanidid anaesthesia, caused neither an anaphylactoid
reaction nor an increase in plasma histamine concentration.
The prick-tests with propanidid made a month after the
third anaesthesia (September 9, 1969) and at 2 months
after the last anaesthesia (November 2, 1970) were negative.
Neither clemastine nor atropine, nor both together, in all
applications, led to an increase of plasma histamine
concentration.
Case No. 2.
This male volunteer who was one of the anaesthetists
in our team was first anaesthetized with propanidid
on March 26, 1969 (7 mg/kg in 7 sec). 10 min before
the injection, he was given atropine 0.01 mg/kg i.v.
During anaesthesia the usual reaction to propanidid was
noted, i.e., brief tachycardia and hypotension; there were
no signs or symptoms of an anaphylactoid reaction. The
plasma histamine level before anaesthesia was 0.8 ng/ml.
At 3, 6, 10 and 20 min after propanidid injection,
concentrations were 1.6, 2.0, 1.5 and 1.5 ng/ml. The
increase of plasma histamine level remained within the
normal range.
On April 24, 1969, he received a second propanidid
anaesthesia in order to study the effect of the injection
speed on histamine release. After premedication with
atropine as above, propanidid 7 mg/kg was injected in
35 sec. 1 min later severe facial erythema developed and
extended over his neck and thorax. As he awoke, he began
to cough and 3 min after injection bronchospasm developed.
At the same time, tachycardia was still present (before
propanidid, 70 beats/min; 4 min later, 110 beats/min).
This intensified to 140 beats/min until at 6 min after
propanidid injection the volunteer had neither a palpable
pulse nor a measurable blood pressure. At the same time,
cyanosis developed and severe oedema was observed in the
face and scalp. Immediately, 500 ml dextran (Longasteril)
and 500 ml glucose (Laevulose) were infused. The intuba-
tion was difficult because of oedema of the glottis. Oxygen
was administered and prednisolone 1 mg/kg injected intra-
venously 8 min after the beginning of anaesthesia. The
pulse and blood pressure were again measurable, and
were 140 beats/min and 80/40 mm Hg. The tachycardia
and hypotension lasted for 30 min. Nausea and headache
were present, and the erythema disappeared first, 24 hours
after narcosis.
The plasma histamine values before and 10 min after
atropine injection were both 0.8 ng/ml. 1, 5, 10 and 20
min after propanidid the levels were 8.6, 26.0, 18.0 and
13.0 ng/ml respectively.
Since we and the volunteer who was, as previously
mentioned, an anaesthetist, were still convinced at
this time that the antihistaminic clemastine could nearly
completely prevent an anaphylactoid reaction after
propanidid injection so that a third anaesthetic was with-
out danger to the volunteer, with the subject's explicit
permission we gave him a third propanidid anaesthesia on
May 29, 1969. This was expected to provide the sought-
after proof that premedication with an antihistamine drug
would prevent the occurrence of incidents during pro-
panidid narcosis.
10 min before propanidid injection 7 mg/kg in 35 sec,
clemastine 0.04 mg/kg and atropine 0.01 mg/kg were
injected intrayenously. After propanidid injection, the
typical short-lived and moderate tachycardia and hypo-
tension occurred (10 mm Hg; 3 min duration), but no
signs or symptoms of an anaphylactoid or allergic reaction
were observed.
The plasma histamine concentration before anaesthesia
was 0.7 ng/ml, and 1, 5, 10 and 20 min after injection of
propanidid 0.7, 1.2, 4.3 and 2.0 ng/ml respectively. The
histamine release in this subject was therefore in accordance
with that of the other subjects.
Prick-tests were performed 4 weeks after the incident
following propanidid injection and 10 weeks after the last
administration of anaesthesia and were found to be
negative. The histamine level and basophil content in whole
blood was 72 ng/ml and 78 cells/mm3, which is in the
normal range. On April 24, 1970, the subject was given
thiopentone 5 mg/kg, in 20 sec, which was without
complication. The histamine concentration in plasma rose
from 0.9 ng/ml before diiopentone to 1.9, 2.1, 1.5 and
1.3 ng/ml, at 3, 6, 10 and 20 min respectively after the
anaesthesia. After 30 min, it reached the base value again
of 0.9 ng/ml. The basophil content of venous whole blood
fell at 3, 6 and 10 min after thiopentone injection to 45,
58 and 58 per cent of the value before anaesthesia. This
is in the normal range (cf. fig. 6). After injection of
Micellophor in the same subject there were no significant
changes in plasma histamine level.
Case No. 3.
As in the case of the previous volunteer the first
propanidid anaesthesia, given on April 9, 1968, was
uncomplicated.
After premedication with atropine 0.01 mg/kg, 1 min
after injection of propanidid 7 mg/kg i.v., in 20 sec, the
expected tachycardia resulted, which, however, lasted
somewhat longer than usual (5 min; before narcosis 93
beats/min; thereafter to a maximum of 111 beats/min).
Furthermore, the typical decrease in blood pressure was
noted, having a maximum of 30 mm Hg, and persisting
until the third minute. The plasma histamine concentration
before anaesthesia was 1.0 ng/ml and at 1, 5, 10, 20 and
30 min after injection, 2.4, 2.6, 3.2, 1.0 and 1.0 ng/ml
respectively. The increase remained, therefore, within the
normal range.
On April 26 a second propanidid injection, after the
same premedication, was administered. 2 min after
injection, 7 mg/kg, in 20 sec, the subject began to cough
and hiccup. Immediately thereafter, erythema of the face
and neck developed which soon proceeded to cyanosis,
since a moderate bronchospasm and a swelling of the
nasal mucosa caused difficulties in breathing. At this time
also, a fine tremor was observed. The tachycardia lasted
17 min (before narcosis, 96 beats/min; 5 min after as the
maximum, 135 beats/min). A blood pressure decrease of
30 mm Hg was measured during the first 5  min after
injection. Approximately 10 min after injection, oedema
of the face and scalp appeared. The subject complained
of headache and dizziness. The persistent cyanosis,
resulting from the breathing difficulties, made it necessary
to administer oxygen. After approximately 1 hour and
without further therapy, the clinical symptoms subsided
to the point where the subject could be transported home.
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The plasma histamine level in this subject before
anaesthesia was 0.85 ng/ml and at 1, 5, 10, 20 and 30 min
after injection of propanidid 8.0, 11.0, 12.0, 3.4 and 1.0
ng/ml respectively. As in the other two cases here reported,
the histamine release following propanidid far exceeded
the normal range. The prick-test response was negative.
Case No. 4.
This subject received for the first time in his life a
propanidid anaesthesia. This was administered on October
16, 1969, in the form of a so-called "one-shot injection"
as part of our investigations on the rapid injection of
propanidid. After premedication with atropine 0.01 mg/kg,
propanidid 7 mg/kg i.v. in 5 sec was injected 10 min later.
2 min after injection, erythema of the face and neck was
noted as well as a slight cramping of the arms and hands.
There was no marked respiratory distress. The blood
pressure was decreased only about 10 mm Hg for a period
of 6 min. A tachycardia lasting 10 min was observed (before
narcosis, 60 beats/min; 5 min after narcosis, still 84
beats/min). The subject complained of a slight headache
and dizziness. No other symptoms of an allergic reaction
were observed.
The plasma histamine level before propanidid injection
was 0.9 ng/ml and 1, 5, 10 and 20 min after injection,
2.6, 6.4, 5.7, and 4.3 ng/ml respectively. Therefore, after
injection of propanidid, the plasma histamine level of this
subject was slightly above those levels of others who had
no actual clinical symptoms and subjective complaints, as
may be seen from the results of histamine infusion (fig. 4).
Relationship between the severity and the course
of clinical symptoms, and the elevation of
plasma histamine levels.
Table II shows a connection between the
severity of the clinical symptoms and the increase
of plasma histamine levels after injection of pro-
panidid. Apparently, the first noticeable symptoms
of histamine release in man are development of
tachycardia and erythema, especially in the skin of
the face in which the highest histamine content is
found of all human skin (Johnson, 1957; Zachariae,
1964; for survey see Lorenz and Werle, 1971). Then
follow bronchospasm, oedema formation and hypo-
tension, the severity of which correlates largely with
the increase of plasma histamine concentration.
The time relationships between the increase and
decrease of the plasma-histamine levels and the
development and disappearance of hypotension and
tachycardia in the foregoing four cases are repre-
sented in figure 7. It shows largely a parallel
development of the three parameters. Only in the
first 3 min after the injection of the anaesthetic
are there effects of propanidid which appear to
have nothing to do with histamine release into the
plasma (see Discussion).
DISCUSSION
By use of indirect methods, histamine release in
man has been shown to follow the use of several
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drugs frequently administered during anaesthesia.
These include:
Muscle relaxants such as tubocurarine (Comroe
and Dripps, 1946; Grob, Lilienthal and Harvey,
1947; Collier and Macauley, 1952; Smith, 1957;
Westgate, Schultz and Van Bergen, 1961; Salem,
King and El Etr, 1968; McDowell and Clarke,
1969); gallamine (Sniper, 1952; Smith, 1957); suxa-
methonium (Bourne, Collier and Gomers, 1952;
Smith, 1957; Jerums, Whittingham and Wilson,
1967).
Ganglionic blocking agents such as trimetaphan
(Mitchell et al., 1951; Payne, 1955).
Anaesthetics such as thiopentone (Carrie and
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FIG. 7. Correlation between plasma histamine con-
centration, pulse rate and blood pressure in four cases of
anaphylactoid and allergic reactions to propanidid. Values
from single determinations. Plasma histamine concentration
is given in ng/ml, blood pressure in mm Hg and pulse
rate in beats/min.
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Buchanan, 1967) and propanidid (Lorenz et al., 1969;
Kay, 1969; Johns, 1970).
Analgesics such as morphine (Salter and White,
1949; Nasmyth and Stewart, 1950) and pethidine
(Finer and Partington, 1953).
Parasympatholytic agents such as atropine (Soil-
man, 1948).
We chose propanidid and thiopentone for our
investigation of histamine release using direct and
indirect methods, because in recent times, and in
regard to thiopentone also in earlier times, there
have been several reports of anaphylactic and ana-
phylactoid incidents in response to administration of
these drugs. The preceding survey shows, however,
that these incidents are in no way specific for both
anaesthetics, but are described for many drugs used
during anaesthesia. With the use of propanidid,
however, the following authors have reported inci-
dents during narcosis with clinical symptoms of
anaphylactoid or allergic reactions: Beck, 1965;
Michel 1965; Radway, 1965; Manz and Frank, 1969;
Kay, 1969; Doenicke and Lorenz, 1970; Johns,
1970; Dannemann and Lubke, 1970; Kriiger, 1970.
Using thiopentone, the following case reports
were published: Hunter, 1943; Moore, 1946; Hay-
ward and Kiester, 1957; Strunk, 1962; Shinohara
and Inamoto, 1965; Currie et al., 1966; Carrie and
Buchanan, 1967; Anderton and Hopton, 1968.
As an explanation for these anaphylactoid and
allergic reactions, different mechanism must be
considered:
(1) Chemical histamine release by both anaesthetics
as a direct effect on histamine stores (chemical
liberators) (Paton, 1956, 1957).
(2) Histamine release by both anaesthetics indirectly
from or in connection with hypoxia, hypercap-
nia and acidosis (co-liberators) (Mongar and
Schild, 1955).
(3) Histamine release due to immunological pro-
cesses, i.e., after sensitization with both anaes-
thetics or by cross-allergy.
(4) Release of kinins, serotonin, slow reacting sub-
stance (SRS), and prostaglandins in connection
with release of histamine or with neural (e.g.,
parasympathetic) mechanisms.
From the present results there is no doubt that
histamine in humans is released in considerable
amounts during anaphylactoid reactions from pro-
panidid. This direct evidence cannot be provided
for thiopentone, because we have not as yet observed
an incident in one of our subjects or patients.
Furthermore, it must be likewise considered proven
on the grounds of the present results that in normal
subjects, propanidid and thiopentone both liberate
histamine in small amounts. The clinical evaluation
of these two facts, however, differs greatly from
each other:
(1) In normal persons histamine release is rela-
tively small. It leads to a pronounced gastric secre-
tion, but to no actual reaction of the circulatory
system. It is, therefore, clinically of little importance.
During anaesthesia, regurgitation and aspiration of
copious gastric juice could possibly occur. Atropine
lessened the histamine-stimulated gastric secretion
and is therefore recommended as premedication.
Histamine release in normal persons is dependent
upon the injection speed (Lorenz et al., 1969). It is
independent of sensitization because it also occurs
after first injection. This supports the view that
propanidid and thiopentone, under these circum-
stances, act as chemical histamine liberators or as
co-liberators. Histamine release in animal experi-
ments using both anaesthetics has not yet been
proved. In the case of propanidid, only the solvent
Micellophor was shown to be a histamine releaser
in dog (see below).
(2) The histamine release occurring during the
investigated incidents was considerable. Sometimes
it led to severe, even to life-threatening, reactions of
the circulatory system and is therefore of critical
clinical importance.
This severe histamine-release reaction occurred in
three of four cases after the second injection of
propanidid. The point in time of the second injection
supports the view of a sensitization in the person.
The decrease of the histamine liberation with an
increasing number of anaesthetics, as in the case of
patient No. 1, supports the view of desensitization.
In spite of negative cutaneous tests, histamine release
is most probably due to immunological reactions.
In the fourth case, however an "allergic" reaction
occurred at the first injection. In the literature it
has been reported that incidents occurred not only
at the second injection, but also at the first injection.
Moreover, the patient showed also abnormally high
plasma histamine levels. Therefore from the pre-
sent state of knowledge, it is in no way justifiable
to explain incidents with propanidid exclusively on
the basis of immunological reactions (for example,
as hapten or hapten-inducer). Although it is unsatis-
factory at present to postulate an elevated sensi-
tivity to histamine liberators or histamine release
in some of the incidents, because for this a bio-
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chemical or morphological substrate has not yet
been identified, this hypothesis appears more
necessary than ever for the moment (cf. Schachter,
1952). The frequency of incidents in patients who
have been exposed to radiation or in patients with
suppurating processes which became obvious in the
case reports (see above) may result from primary
diseases which produce increased sensitivity to
histamine liberators. Exact investigations in this
respect have been hitherto unavailable.
With thiopentone, all case reports known to us
refer to a sensitization. Histamine release as a result
of immunological reactions appears to stand in the
foreground.
The question of a release of other vasoactive
substances in adverse reaction to propanidid and
thiopentone raises at the same time another question
about the pathophysiological and clinical importance
of histamine release. When histamine is released
from mast cells as a direct effect of the anaesthetic
or mediated by immune reactions, depending upon
species and body region, also many other substances
are liberated, such as serotonin, catecholamines, and
heparin, as well as proteolytic enzymes, which form
vasoactive polypeptides such as bradykinin and
kallidin.
Calculations on the basis of recent investigations
on pig and dog (Messmer et al., 1970; Lorenz et al.,
1971a, b), which can here be employed, help to
provide an answer. When histamine is released in
these two species by the classical histamine liberator
48/80, or in dogs by macromolecular substances
such as gelatine, Cremophor or Micellophor, then
a highly significant correlation exists between the
extent of the peripheral arterial hypotension and
the increase of histamine concentration in plasma.
Since it was shown that the fall in arterial pressure,
but not the histamine release, was largely prevented
by antihistaminics in animal experiments, there
exists not only an accidental parallelism, but a
causal connection between histamine release and the
fall in blood pressure.
Because of the proportionality between the fall in
pressure and the increase in plasma histamine con-
centration, it can be determined in what range of
histamine concentrations a severe hypotension (over
60 mm Hg) or even a life-threatening incident occurs
in test animals. In pigs, the range of plasma hista-
mine concentrations is about 50-100 ng/ml (Lorenz
et al., 1971a), in dogs about 35-90 ng/ml (Messmer
et al., 1970). Dogs and pigs exhibit nearly the same
sensitivity to histamine, taking into consideration the
blood pressure response of these animals. Humans
react, however, with at least twice the sensitivity of
these species. In man, therefore, on this basis an
elevation of the plasma histamine concentration of
about 20-50 ng/ml would be enough to cause
severe hypotension progressing to cardiovascular
arrest. This degree of increase in histamine concen-
tration was in fact measured in cases 1 and 2.
Our calculations make it highly probable, there-
fore, that histamine release represents the real cause
of the incidents observed after propanidid injection.
This view is further supported by the observation
that the severity of the clinical symptoms paralleled
the extent of histamine release (table II), and the
development and cessation of clinical symptoms
corresponded with the increase and decrease of the
plasma histamine concentration (fig. 7).
The release of other tissue hormones may increase
or reduce the histamine effect on the circulation but
lack of experimental data concerning the quantities
of these substances released during anaesthesia rend-
ers discussion of the role of these substances largely
speculative.
The demonstration of the presence of a vaso-
active substance in severe hypotensive reactions
caused by anaesthetics allows too easily the con-
venience of attributing all circulatory reactions after
injection of propanidid and thiopentone to histamine
release into the blood stream. This is in no way
true. Neither for reason of the quantity of histamine
released (cf. histamine infusion, fig. 4) nor for reasons
of the time-course of histamine release (cf. fig. 7)
can tachycardia and hypotension after propanidid
narcosis and after thiopentone narcosis be attributed
to histamine release into the blood stream in the
first 1-3 min after injection of the anaesthetics.
According to investigations previously reported,
hypotension during propanidid narcosis was (1)
explained by myocardial depression (Bernhoff, 1963;
Astrom, Bernhoff and Persson, 1970; Lennartz,
Zindler and Hepfer, 1970; Soga and Beer, 1971,
personal communication) and (2) by peripheral vaso-
dilatation on the basis of a direct action of propani-
did on smooth muscle (Langrehr, 1965, 1968). As
noted, the hypotension induced by histamine release
shows itself as a "delayed blood pressure response"
and in general reaches its maximum 5-7 min after
the administration of the histamine releaser.
The best way to demonstrate the two different
causes of hypotension after propanidid injection is
by administration of this anaesthetic to dogs. In this
species, Cremophor or Micellophor, the solvent of
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propanidid, acts as a macromolecular histamine
releaser (Wirth and Hoffmeister, 1965; Lorenz et al.,
1971b). After the typical initial hypotension and
tachycardia, and after a short, more or less complete
return to normal, there follows a second, much more
severe, hypotension of longer duration (Conway, Ellis
and King, 1967; Lorenz et al., unpublished).
This second episode of hypotension is caused by
histamine (Lorenz et al., 1971b). One can demon-
strate the same reaction only in cat, but not in
rabbit, pig and man, in which species, Cremophor is
not a histamine liberator (Lorenz et al., 1969, 1971a,
b; Doenicke and Lorenz, 1970).
Our investigations during the described incidents
give indications for therapy as follows. Glucocorti-
coids, antihistaminics and plasma substitutes (see
Doenicke and Lorenz, 1970), should prevent the
reactions to a massive histamine release. Antihist-
aminics, in the usual doses as premedication, attain
only a mitigating effect, but in severe incidents they
do not suffice to block completely the action of
histamine on the receptors. Therefore, it is recom-
mended that antihistaminics should be included in
preanaesthetic medication, in order to prevent slight
allergic reactions and, if severe reactions occur, to
inject a high dose of prednisolone immediately as a
functional antagonist to histamine.
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LIBERATION D'HISTAMINE CHEZ L'HOMME
CONSECUTIVE A L'ADMINISTRATION DE
PROPANIDIDE ET DE THIOPENTONE: EFFETS
PHARMACOLOGIQUES ET CONSEQUENCES
CLINIQUES
SOMMAIRE
En recourant a un nouveau procede' specifique et extreme-
ment sensible, en vue du dosage de rhistamine presente
dans le plasma humain, on a montre que l'injection de
propanidide et de thiopentone etait suivie d'une liberation
histaminique. L'etude de la secretion gastrique, de la
pression arterielle et de la frequence cardiaque a confirm^
cette decouverte. Chez des sujets normaux, la libdration
d'histamine ne presente aucune signification clinique par-
ticuliere. D'autre pan, lorsque des reactions de type
anaphylactique sont survenues a la suite d'une injection
de propanidide, la liberation d'histamine dtait suffisamment
massive pour expliquer la severite des symptomes et signes
cliniques observes. Au cours de cette etude, aucune
reaction n'a ete notee a la suite de l'injection de thiopen-
tone. Bien qu'il semble vraisemblable qu'une liberation
massive d'histamine puisse survenir au cours de reactions
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de type anaphylactique engendrees par cet agent anes-
thesique, nous ne disposons d'aucune observation pour le
confirmer. Dans un cas, on a montre qu'une premedication
comportant i'administration de glucocorticoides et de sub-
stances antihistaminiques et un traitement a base de sub-
stituts du plasma, pouvaient s'opposer a l'apparition d'une
reaction grave.
HISTAMINFREISETZUNG DURCH PROPANIDID
UND THIOPENTONE AM MENSCHEN:
PHARMAKOLOGISCHE WIRKUNGEN
UND KLINISCHE FOLGERUNGEN
ZUSAMMENFASSUNG
Mit einer neuen, hoch empfindlichen und spezifischen
Methode zur Bestimmung von Histamin in menschlichem
Plasma konnte gezeigt werden, dafi die Injektion von
Propanidid und Thiopentone eine Histaminfreisetzung
hervprruft. Beobachtungen der Magensaftsekretion, des
arteriellen Blutdrucks und der Pulsfrequenz unterstutzten
diese Befunde. Bei Normalpersonen fuhrte die Histamin-
freisetzung nicht zu klinischen Erscheinungen. Wenn
jedoch nach Propandidid-Injektion anaphylaktoide Reak-
tionen auftraten, war die Histaminfreisetzung jeweils so
massiv, daB man aus ihr die schweren klinischen Zeichen
und Symptome ableiten konnte. Bei dieser Untersuchung
war die Injektion von Thiopentone von keinen Reaktionen
gefolgt. Obwohl es wahrscheinlich scheint, bafi bei Ver-
wendung von diesem Anaesthetikum massive Histamin-
freisetzungen unter anaphylaktoiden Reaktionen auftreten,
konnten wir mit unseren Beobachtungen dies nicht
bestatigen. In einem Fall konnte gezweigt werden, da6
Pramedikation mit Glucocoricoiden und Antihistaminika
sowie Therapie mit Plasma-Substitution die Entwicklung
einer schweren Reaktion verhindern konnte.
LIBERACION DE HISTAMINA EN EL HOMBRE
POR PROPANIDID Y TIOPENTONA:
EFECTOS FARMACOLOGICOS Y
CONSECUENCIAS CLINICAS
RESUMEN
Utilizando un nuevo metodo, muy sensible y especifico,
para la determinacion de histamina en el plasma humano,
se demostro que despues de la inyeccidn de propanidid y
tiopentona hay liberacion de histamina. La observacion
de la secrecion gastrica, presi6n arterial y frecuencia del
pulso apoyo este hallazgo. La liberacion de histamina no
tiene ninguna importancia clinica especial en personas
normales. Por otra parte, cuando ocurrieron reacciones
anafilactoides despues de la inyecci6n de propanidid, la
liberacion de histamina fue tan masiva que podia explicar
diversos signos y sintomas clinicos observados. En este
estudio no ocurrieron reacciones despues de la inyeccion
de tiopentona. Aunque parece probable que puede haber
un desprendimiento masivo de histamina durante
reacciones anafilactoides con este anestisico, no poseemos
observaciones que puedan confirmarlo. En un caso fue
demostrado que la premedicaci6n con glucocorticoides e
histaminicos y la terapia con sustirutos de plasma pueden
impedir el desarrollo de una reacci6n intensa.
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